Houston, TX5 Active Studies

Liver Cancer Clinical Trials in Houston, TX

Find 5 actively recruiting liver cancer clinical trials in Houston, TX. Connect with local research sites and explore new treatment options.

5
Active Trials
5
Sponsors
668
Enrolling

Recruiting Liver Cancer Studies in Houston

RecruitingHouston, TXNCT06795022

First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours

This research is designed to determine if experimental treatment with AZD9793, a T cell-engaging antibody that targets GPC3, is safe, tolerable and has anti-cancer activity in patients with advanced o...

304 participants
AstraZeneca
View Study Details
RecruitingHouston, TXNCT05797805

A Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma

This study will be conducted in 2 parts. The first part is a phase 1 single-agent dose escalation, and dose optimization, study of tegavivint in patients with advanced HCC after failure of at least on...

178 participants
Iterion Therapeutics
View Study Details
RecruitingHouston, TXNCT05727176

Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement

This is an open-label, multinational, randomized Phase 2 study confirming the clinical benefit of 20 mg futibatinib and evaluating the safety and efficacy of 16 mg futibatinib in previously treated CC...

120 participants
Taiho Oncology, Inc.
View Study Details
RecruitingHouston, TXNCT03897543

ABX196 in Combination With Nivolumab in Patients With Hepatocellular Carcinoma

Open-label, uncontrolled, phase 1-2 study to evaluate the safety, tolerability, pharmacodynamic effects, and preliminary efficacy of ABX196 administered in combination with nivolumab in patients with ...

48 participants
Abivax S.A.
View Study Details
RecruitingHouston, TXNCT04134559

Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma

This research study is studying an immunotherapy drug (pembrolizumab or KEYTRUDA) as a possible treatment for pediatric hepatocellular carcinoma or hepatocellular neoplasm not otherwise specified (HCN...

18 participants
Allison O'Neill, MD
View Study Details

About Liver Cancer Clinical Trials in Houston

Liver cancer most commonly presents as hepatocellular carcinoma (HCC) and is often associated with chronic liver disease or hepatitis. It is one of the fastest-growing causes of cancer death. Treatment options include surgery, liver transplant, ablation, and systemic therapies.

There are currently 5 liver cancer clinical trials recruiting participants in Houston, TX. These studies are seeking a combined 668 participants. Research is being sponsored by AstraZeneca, Iterion Therapeutics, Taiho Oncology, Inc. and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Liver Cancer Clinical Trials in Houston — FAQ

Are there liver cancer clinical trials in Houston?

Yes, there are 5 liver cancer clinical trials currently recruiting in Houston, TX. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Houston?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Houston research site will contact you about next steps.

Are clinical trials in Houston free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Houston studies also compensate for your time and travel.

What liver cancer treatments are being tested?

The 5 active trials in Houston are testing new therapies including novel drugs, biologics, and treatment approaches for liver cancer.

Data updated March 2, 2026 from ClinicalTrials.gov